Search - tctmd.com

Displaying 1 - 16 of 16

Sort: Relevancy | Date

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

News Daily News

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Michael O'Riordan

October 02, 2020

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Conference News ESC 2020

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

L.A. McKeown

September 03, 2020

News Daily News

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

L.A. McKeown

July 23, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

Caitlin E. Cox

June 25, 2020

News Daily News

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

Yael L. Maxwell

May 25, 2020

News Daily News

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

Yael L. Maxwell

May 15, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Conference News ACC 2020

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

L.A. McKeown

April 02, 2020

News Conference News ACC 2020

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

Yael L. Maxwell

March 31, 2020

News Opinion Editor's Corner

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

Shelley Wood

March 16, 2020

News Conference News ISET 2020

PERT Data Emerge, Though the Exact Strategy Isn’t a Done Deal

Caitlin E. Cox

January 30, 2020

Presentation CACI 2019

¿Qué papel juegan actualmente los nuevos anticoagulantes en la prevención del stroke?

Presenter: Nicolás Gonzalez

November 29, 2019

Advertisement

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Study Affirms Thrombotic Risk in COVID-19

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban

COVID-19 Patients With Arterial Leg Thromboses Risk Amputation and Death

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Rivaroxaban May Yet Protect After a Hospital Stay: MARINER

‘Relatively Low’ Stroke Incidence in COVID-19, but More Are Cryptogenic

P2Y12 Inhibitor Monotherapy Edges Out Aspirin for Secondary Prevention

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy

PRONOMOS: Rivaroxaban Beats Enoxaparin for Preventing VTE After Orthopedic Surgery

A ‘Virtual’ ACC 2020? TCTMD Has You Covered, However Things Roll Out

PERT Data Emerge, Though the Exact Strategy Isn’t a Done Deal

¿Qué papel juegan actualmente los nuevos anticoagulantes en la prevención del stroke?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content